A detailed history of Charles Schwab Investment Management Inc transactions in Glaukos Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 641,761 shares of GKOS stock, worth $91.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
641,761
Previous 434,423 47.73%
Holding current value
$91.8 Million
Previous $51.4 Million 62.62%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.62 - $135.39 $23.6 Million - $28.1 Million
207,338 Added 47.73%
641,761 $83.6 Million
Q2 2024

Aug 12, 2024

BUY
$89.48 - $118.35 $2.41 Million - $3.18 Million
26,888 Added 6.6%
434,423 $51.4 Million
Q1 2024

May 08, 2024

BUY
$76.4 - $96.33 $1.17 Million - $1.47 Million
15,295 Added 3.9%
407,535 $38.4 Million
Q4 2023

Feb 06, 2024

BUY
$59.53 - $85.11 $324,438 - $463,849
5,450 Added 1.41%
392,240 $31.2 Million
Q3 2023

Nov 08, 2023

BUY
$69.23 - $79.09 $1.41 Million - $1.61 Million
20,415 Added 5.57%
386,790 $29.1 Million
Q2 2023

Aug 09, 2023

BUY
$45.44 - $71.21 $491,706 - $770,563
10,821 Added 3.04%
366,375 $26.1 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $184,120 - $220,206
4,196 Added 1.19%
355,554 $17.8 Million
Q4 2022

Feb 13, 2023

BUY
$40.82 - $57.75 $289,985 - $410,256
7,104 Added 2.06%
351,358 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $542,079 - $676,904
11,573 Added 3.48%
344,254 $18.3 Million
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $205,918 - $376,689
-5,907 Reduced 1.74%
332,681 $15.1 Million
Q1 2022

May 13, 2022

BUY
$44.33 - $57.82 $300,867 - $392,424
6,787 Added 2.05%
338,588 $19.6 Million
Q4 2021

Feb 11, 2022

BUY
$40.27 - $56.99 $430,486 - $609,223
10,690 Added 3.33%
331,801 $14.7 Million
Q3 2021

Nov 16, 2021

BUY
$47.43 - $84.23 $167,001 - $296,573
3,521 Added 1.11%
321,111 $15.5 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $931,003 - $1.24 Million
12,743 Added 4.18%
317,590 $26.9 Million
Q1 2021

May 17, 2021

BUY
$70.43 - $97.42 $855,020 - $1.18 Million
12,140 Added 4.15%
304,847 $25.6 Million
Q4 2020

Feb 16, 2021

BUY
$48.9 - $75.26 $235,893 - $363,054
4,824 Added 1.68%
292,707 $22 Million
Q3 2020

Nov 13, 2020

BUY
$37.23 - $50.97 $652,753 - $893,657
17,533 Added 6.49%
287,883 $14.3 Million
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $747,502 - $1.22 Million
25,973 Added 10.63%
270,350 $10.4 Million
Q1 2020

May 15, 2020

BUY
$25.53 - $70.14 $89,559 - $246,051
3,508 Added 1.46%
244,377 $7.54 Million
Q4 2019

Feb 07, 2020

BUY
$54.18 - $65.64 $1.17 Million - $1.42 Million
21,591 Added 9.85%
240,869 $13.1 Million
Q3 2019

Nov 08, 2019

BUY
$58.58 - $83.91 $1.02 Million - $1.46 Million
17,361 Added 8.6%
219,278 $13.7 Million
Q2 2019

Aug 09, 2019

BUY
$63.59 - $78.71 $621,337 - $769,075
9,771 Added 5.09%
201,917 $15.2 Million
Q1 2019

May 14, 2019

BUY
$50.75 - $80.54 $403,310 - $640,051
7,947 Added 4.31%
192,146 $15.1 Million
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $168,697 - $219,617
3,233 Added 1.79%
184,199 $10.3 Million
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $421,603 - $755,967
11,057 Added 6.51%
180,966 $11.7 Million
Q2 2018

Aug 08, 2018

BUY
$27.62 - $44.51 $618,577 - $996,845
22,396 Added 15.18%
169,909 $6.91 Million
Q1 2018

May 07, 2018

BUY
$26.05 - $34.5 $212,255 - $281,106
8,148 Added 5.85%
147,513 $4.55 Million
Q4 2017

Jan 17, 2018

SELL
$24.5 - $36.01 $80,605 - $118,472
-3,290 Reduced 2.31%
139,365 $3.58 Million
Q3 2017

Nov 13, 2017

BUY
$31.26 - $42.03 $4.46 Million - $6 Million
142,655
142,655 $4.71 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.81B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.